Figure 4.
Neurotransmitters based therapy in Alzheimer’s disease such as cholinesterase inhibitors, NMDA receptor inhibitors, GABAergic modulators, serotonin receptor modulators, histaminergic modulators, and adenosine receptor modulators [211].
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.